INS and type 1 diabetes mellitus: Treatment with continuous s.c. insulin infusion (CSII) provides better glycemic control for patients with type 1 diabetes mellitus than conventional therapy with multiple daily insulin injections, with a lower frequency of hypoglycemia and lesser insulin doses (1).